Biomechanical Control of Lysosomal Secretion Via the VAMP7 Hub: A Tug-of-War between VARP and LRRK1
ISCIENCE
Authors: Wang, Guan; Nola, Sebastien; Bovio, Simone; Bun, Philippe; Coppey-Moisan, Maite; Lafont, Frank; Galli, Thierry
Abstract
The rigidity of the cell environment can vary tremendously between tissues and in pathological conditions. How this property may affect intracellular membrane dynamics is still largely unknown. Here, using atomic force microscopy, we show that cells deficient in the secretory lysosome v-SNARE VAMP7 are impaired in adaptation to substrate rigidity. Conversely, VAMP7-mediated secretion is stimulated by more rigid substrate and this regulation depends on the Longin domain of VAMP7. We further find that the Longin domain binds the kinase and retrograde trafficking adaptor LRRK1 and that LRRK1 negatively regulates VAMP7-mediated exocytosis. Conversely, VARP, a VAMP7- and kinesin 1-interacting protein, further controls the availability for secretion of peripheral VAMP7 vesicles and response of cells to mechanical constraints. LRRK1 and VARP interact with VAMP7 in a competitive manner. We propose a mechanism whereby biomechanical constraints regulate VAMP7-dependent lysosomal secretion via LRRK1 and VARP tug-of-war control of the peripheral pool of secretory lysosomes.
Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease
MECHANISMS OF AGEING AND DEVELOPMENT
Authors: Dachsel, Justus C.; Nishioka, Kenya; Vilarino-Gueell, Carles; Lincoln, Sarah J.; Soto-Ortolaza, Alexandra I.; Kachergus, Jennifer; Hinkle, Kelly M.; Heckman, Michael G.; Jasinska-Myga, Barbara; Taylor, Julie P.; Dickson, Dennis W.; Gibson, Rachel A.; Hentati, Faycal; Ross, Owen A.; Farrer, Matthew J.
Abstract
LRRK2 mutations are recognized as the most frequent genetic cause of both familial and sporadic parkinsonism identified to date. A remarkable feature of this form of parkinsonism is the variable penetrance of symptom manifestation resulting in a wide range of age-at-onset in patients. Herein we use a functional approach to identify the Lrrk1 protein as a potential disease modifier demonstrating an interaction and heterodimer formation with Lrrk2. In addition, evaluation of LRRK1 variants in our large Lrrk2 p.G2019S-parkinsonism series from a Tunisian (n = 145) identified a missense mutation (p.L416M) resulting in an average 6.2 years younger age at disease onset. In conclusion we show that the interaction of Lrrk1-Lrrk2 can form protein dimers and this interaction may influence the age of symptomatic manifestation in Lrrk2-parkinsonism patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.